Link between gut‐microbiome derived metabolite and shared gene‐effects with hepatic steatosis and fibrosis in NAFLD

Caussy, Cyrielle, Hsu, Cynthia, Lo, Min‐Tzu, Liu, Amy, Bettencourt, Ricki, Ajmera, Veeral H., Bassirian, Shirin, Hooker, Jonathan +9 more·2018·Hepatology
DOI 10.1002/hep.29892

Cited by (208)

Items 201–208 of 208

  1. Additional file 1 of Effect of environmental variance-based resilience selection on the gut metabolome of rabbits
    Cristina Casto‐Rebollo, Argente, María José, García, María Luz, A. Blasco, Ibáñez-Escriche, Noelia · 2024 · Figshare
  2. Additional file 2 of Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease
    Qian Zhu, Qin, Min, Wang, Zixian, Wu, Yonglin, Chen, Xiaoping, Liu, Chen, Qilin Ma, Liu, Yibin, Lai, Weihua, Chen, Hui et al. · 2022 · Figshare
  3. Additional file 2 of Effect of environmental variance-based resilience selection on the gut metabolome of rabbits
    Cristina Casto‐Rebollo, Argente, María José, García, María Luz, A. Blasco, Ibáñez-Escriche, Noelia · 2024 · Figshare
  4. Probiotics for managing non-alcoholic fatty liver disease: efficacy and mechanistic insights
    Supriyo Ghosh, Amlan Jyoti Ghosh, Manab Deb Adhikari, Bipransh Kumar Tiwary, Tilak Saha · 2026 · Journal of Diabetes & Metabolic Disorders
  5. Bacteroides cellulosilyticus -derived 2-hydroxyphenylacetic acid rectifies hepatic lipid homeostasis in MASLD by targeting the PPARγ-CD36 axis
    Kaiwei Chen, Zizhen Yang, Jixing Peng, Chunyan Liu, Ying Yu, Xinchi Cai, Bei Liu, Shuao Li, Tiantian Chen, Samil Jung et al. · 2026 · Gut Microbes
  6. Marine polysaccharides: promising nutraceuticals for metabolic dysfunction-associated steatotic liver disease as unique and potent modulator of gut microbiome
    Yuanjie Pan, Ruijie Zhang, Yuping Chen · 2026 · Food Science and Biotechnology
  7. Emerging Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Current Evidence, Clinical Utility, and Future Perspectives
    Sushant S Dhanavade, Mandakini S. Kshirsagar, Axita C Vani, Altaf K Mujawar, Pankaj V Bansode · 2026 · Cureus
  8. Therapeutic opportunities of fecal microbiota transplantation in the treatment of non-alcoholic fatty liver disease
    Ying Chen, Yu Li, Xiao Li, Xinxin Xu, Shiyao Chen · 2026 · Frontiers in Cellular and Infection Microbiology